Murphysboro / Houston / Watson / Aldrich / Oxford / Philadelphia / Washington / Shreveport / Geneva / Westchester / Rochester / Seattle / New York / Island Hospital Providence / Nelson / Phoenix / /
Company
Lang AE / Rogers AE / McCall / Patient Group / Dosing Strategy Primary Study Outcomes Conclusions Group / Medline / Case / GM / /
Continent
Europe / /
Country
Switzerland / Netherlands / France / Canada / United Kingdom / Germany / United States / Czech Republic / / /
Facility
Hospital Providence / Sinai Medical Center / 4Houston Sleep Center / Barrow Neurological Institute / 8Louisiana State University / AASM Mayo Clinic / University of California / Joseph Memorial Hospital / American College of Physicians / Chapel Hill / Univ Hospital of Geneva / / /
IndustryTerm
transportation / treatment of recurrent hypersomnia and behavioral symptoms / treatment of sleepiness in specific hypersomnia disorders / treatment of the narcoleptic syndrome / treatment of cataplexy and related symptoms / healthcare / pharmaceutical / treatment of attention deficit disorder / treatment of these disorders / /
Aurora RN / Central Origin An American Academy of Sleep Medicine Report Timothy I. Morgenthaler / One Westbrook Corporate Center / Practice Committee of the AASM / 6Mount Sinai Medical Center / 9Stanford University / American College / Barrow Neurological Institute / American Academy of Sleep Medicine / 8Louisiana State University / University of California / Los Angeles / Joseph Memorial Hospital / 4Houston Sleep Center / Practice Committee / Stanford / /
Person
Zarcone / Andrew L. Chesson Jr. / R. Nisha Aurora / Judith Owens / Terry M. Brown / Timothy I. Morgenthaler / Brian Boehlecke / Todd J. Swick / Daytime Sleepiness (Objective) / Cathy Alessi / Jeffrey Pancer / Leah Friedman / Vishesh K. Kapur / Rama Maganti / Placebo Daytime Sleepiness / / /
Minnesota / New York / Washington / Montana / Rhode Island / Mississippi / Nova Scotia / California / Arizona / Texas / Illinois / Newfoundland / North Carolina / /